european medicines agency glp-1 vision loss recommendation november 2025 Possible Link Between RA Medications & Eye Health GLP-1 Agonists Weight Loss Drugs

NAION and GLP-1 RAs Recent studies have indicated a possible link between GLP-1 receptor agonists semaglutide and liraglutide and an increased risk of NAION, or non-arteritic anterior ischemic optic neuropathy

Reflecting this, a recent assessment of the states that use the federally facilitated marketplace (Healthcare.gov) found that fewer than 1% of plans covered Wegovy for weight loss

It details the peptides role in stimulating blood vessel and nerve outgrowth, increasing the synthesis of collagen, elastin, and glycosaminoglycans, and supporting dermal fibroblast function

There are many other substances that are natural that have AS profound of an effect, like that of turmeric

Your semaglutide stays at $200 for five weeks of treatment and your tirzepatide at $275, regardless of what dose your provider prescribes

Do not exceed recommended dosage